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Abstract
Familial apparently balanced translocations (ABTs) segregating with discordant phenotypes
are extremely challenging for interpretation and counseling due to the scarcity of publica-
tions and lack of routine techniques for quick investigation. Recently, next generation
sequencing has emerged as an efficacious methodology for precise detection of transloca-
tion breakpoints. However, studies so far have mainly focused on de novo translocations.
The present study focuses specifically on familial cases in order to shed some light to this
diagnostic dilemma. Whole-genome mate-pair sequencing (WG-MPS) was applied to map
the breakpoints in nine two-way ABT carriers from four families. Translocation breakpoints
and patient-specific structural variants were validated by Sanger sequencing and quantita-
tive Real Time PCR, respectively. Identical sequencing patterns and breakpoints were iden-
tified in affected and non-affected members carrying the same translocations. PTCD1,
ATP5J2-PTCD1, CADPS2, and STPG1 were disrupted by the translocations in three fami-
lies, rendering them initially as possible disease candidate genes. However, subsequent
mutation screening and structural variant analysis did not reveal any pathogenic mutations
or unique variants in the affected individuals that could explain the phenotypic differences
between carriers of the same translocations. In conclusion, we suggest that NGS-based
methods, such as WG-MPS, can be successfully used for detailed mapping of translocation
breakpoints, which can also be used in routine clinical investigation of ABT cases. Unlike de
novo translocations, no associations were determined here between familial two-way ABTs
and the phenotype of the affected members, in which the presence of cryptic imbalances
and complex chromosomal rearrangements has been excluded. Future whole-exome or
whole-genome sequencing will potentially reveal unidentified mutations in the patients
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underlying the discordant phenotypes within each family. In addition, larger studies are
needed to determine the exact percentage for phenotypic risk in families with ABTs.
Introduction
Apparently balanced translocations (ABTs) involve the exchange of genomic regions between
non-homologous chromosomes, without the gain or loss of genetic material. The majority of
ABT carriers are phenotypically normal; however, an association with abnormal phenotypes,
including intellectual disability (ID) and other congenital abnormalities, has been estimated in
6–9% of de novo cases [1,2]. For familial ABTs present in phenotypically normal individuals, it
is generally considered that the risk of phenotypic abnormality in their balanced offspring is
very low. Even though the risk is low, there are many cases reported where ABTs present in
phenotypically normal carriers have been associated with abnormal phenotypes in related
patients [3–6].
Several mechanisms have been proposed to explain how familial ABTs can be implicated in
the development of this type of clinical discordancy. Work performed by our group using
Fluorescence In Situ Hybridization (FISH) [5] and array-Comparative Genomic Hybridization
(array-CGH) [7] showed that in a number of cases it could be explained by the presence of
cryptic, submicroscopic imbalances or complex chromosomal rearrangements (CCRs). A sec-
ond mechanism could be functional homozygosity due to gene disruption by the translocation
on one allele and unmasking of a recessive gene mutation on the allele inherited from the
other parent [8]. Familial ABTs can also cause discordant phenotypes by disruption of
imprinted genes [9,10]. Another possible mechanism is “position effect” with variable expres-
sion of genes near the translocation or other identified rearrangement breakpoints [11,12].
Finally, reduced penetrance is a well-known observation in many dominant traits [13,14].
Several cytogenetic and molecular methods such as chromosomal G-banding, FISH [5],
array-CGH [7,15,16], and array painting [17–19] have been applied throughout the years to
characterize ABTs in individuals with an abnormal phenotype. However, molecular cyto-
genetic techniques have their individual limitations, and can often be technically challenging
and time-consuming [20]. In addition, these methods cannot define the rearrangement at
nucleotide level and may fail in identifying smaller chromosomal imbalances [20,21]. The
exact characterization of translocation breakpoints and/or identification of any cryptic geno-
mic imbalances and complex rearrangements in ABT carriers are crucial for identifying single
disease candidate genes at or near the breakpoints, as well as understanding the molecular
mechanisms underlying such events. This, in turn, will aid in the accurate correlation of the
chromosomal rearrangement(s) with the clinical phenotype [22].
Recent studies have demonstrated that next generation sequencing (NGS) is a powerful tool
for characterizing and mapping translocations at the nucleotide level. Targeted [20,23,24] and/or
whole-genome NGS approaches [25–27], have so far been aimed at the investigation of de novo
translocations. To date, there is a very limited bibliography regarding familial ABTs, which conse-
quently leads to several diagnostic dilemmas about prenatal diagnosis and phenotypic risk.
In the current study, we present a whole-genome next generation mate-pair sequencing
(WG-MPS) investigation to rapidly and accurately map translocation breakpoints in nine
familial two-way ABT carriers from four families. All samples have been previously analyzed
with G-banding, FISH, and array-CGH to exclude any submicroscopic imbalances. Our main
aim was to characterize the translocations in each family to the base-pair (bp) level, identify
disease candidate genes, and possibly reveal additional structural rearrangements that could
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explain the phenotypic differences between family members carrying the same translocation.
This is, to the best of our knowledge, the largest study applying NGS methodologies for the
investigation of familial ABT cases with discordant phenotypes. We demonstrate that
WG-MPS, together with PCR and Sanger sequencing, allowed successful delineation of 18
translocation breakpoints to the nucleotide level, identification of four genes disrupted at the
breakpoints, as well as investigation of the possible mechanisms underlying ABT generation.
As previously suggested, we also support the use of NGS-based methods for the clinical investi-
gation of ABT carriers.
Materials and Methods
Consent Form Collection, Study Participants, and Preliminary Analyses
This study was approved by the National bioethics committee as part of the Translation Facil-
ity Application with number EEBK/EP/2-13/09. Written informed consent was obtained
from all participants, or adults responsible for children, before the beginning of this study.
Nine familial apparently balanced translocation (ABT) cases, from four different families,
were included in this study. Each family had at least one clinically affected and one non-
affected carrier of the same translocation.
Karyotype analysis using G-banding at the 550–750 band level on cultured lymphocyte
metaphases, FISH using subtelomeric specific probes and/or whole chromosome paints [5], as
well as array-CGH [7] with 1Mb or 200kb resolution chip were previously performed accord-
ing to standard protocols.
Mate-Pair Library Preparation and Sequencing
DNA samples were extracted from blood with the QIAamp DNA Blood Midi Kit (Qiagen, Hil-
den, Germany) according to the manufacturer’s recommendations. The concentration/quality
of all DNA samples was quantified, prior to use, with NanoDrop. Mate-pair libraries were pre-
pared by following the Nextera Mate-Pair Sample Preparation Guide, gel-free protocol (Part
#15035209 Rev.C) obtained from Illumina’s webpage (http://www.illumina.com/) and using
the Nextera Mate-Pair Sample Preparation kit (Illumina, San Diego, CA, USA).
In brief, 1 μg of genomic DNA was fragmented into 2-4kb inserts and tagged with a biotiny-
lated mate-pair junction adaptor using a mate-pair tagment enzyme. The short single-stranded
sequencing gaps left from the tagmentation reaction were filled using a strand displacement
polymerase. The DNA fragments were then purified using Agencourt AMPure XP beads
(Beckman Coulter Inc., Brea, CA, USA) followed by DNA fragment circularization and blunt-
end ligation using a circularization ligase enzyme. The large circularized molecules were
digested by sonication into smaller-sized fragments of ~200-400bp. Following that, biotiny-
lated mate-pair DNA fragments were isolated by binding to streptavidin-coated beads (Dyna-
beads1 M-280 Streptavidin—Invitrogen, Life Technologies, Carlsbad, CA, USA), and end-
repaired to convert overhangs into blunt ends. A single ‘A’ nucleotide was added to the 3’ends
of the fragments, which served to ligate Illumina TruSeq paired-end index adapters containing
a complimentary ‘T’ nucleotide overhang. The mate-pair libraries were PCR amplified and the
amplified products were purified with AMPure XP beads (Beckman Coulter Inc.). The final
concentration of the mate-pair libraries was measured with Quant-iT™ PicoGreen1 (Invitro-
gen) by following standard procedures. MPS libraries from each sample were diluted accord-
ingly in water to 10nM and pooled into groups of four. Each pool was sequenced, as 100-bp
paired-end reads, on a single flow-cell lane of the Illumina HiSeq2500 (Illumina) following the
manufacturer’s protocol.
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Analysis of Mate-Pair Sequencing Data
Biotinylated adapter sequences were removed prior to alignment of high quality paired-end
reads to the human reference genome GRCh37/hg19 using Burrows-Wheeler Aligner (BWA)-
MEM with default parameters [28]. Reads not aligning uniquely as well as PCR duplicates
were not analysed further. SVDetect was then used to identify potential translocations, inver-
sions and large deletions/insertions from discordant paired-end data [29] aligning on different
chromosomes, with unexpected strand orientation and at a distance deviating from the pre-
defined insert length, respectively. These predicted structural variants (SVs) were also com-
pared with in-house MPS data sets in order to identify SVs uniquely present in our familial
ABT samples. Only SV predictions supported by at least five independent read-pairs were
taken into consideration for further analysis. Visualization of the processed MPS data was per-
formed using Integrative Genomics Viewer (IGV) (Broad Institute) [30] and the UCSC
Genome Browser [31] (https://genome.ucsc.edu/).
Translocation Breakpoints Validation
PCR primer pairs (Metabion, Planegg, Germany) were designed flanking the breakpoint junc-
tion of each reconstructed derivative chromosome using the Primer3 web interface tool [32]
(http://bioinfo.ut.ee/primer3-0.4.0/) (S1 and S2 Figs, S1 Supporting Document). PCR amplifi-
cation was performed in a 25μl reaction containing DNA sample, forward and reverse PCR
primers (10μM) (Metabion), PCR buffer (1X) (Applied Biosystems, Life Technologies, Foster
City, CA, USA), dNTPs (200μM) (Sigma-Aldrich, St. Louis, MO, USA), AmpliTaq polymerase
(0.025μM) (Applied Biosystems), and dH20. PCR primer sequences and conditions are listed
in S1 Table. Amplified products were visualized on a 2% agarose gel, which was stained in
ethidium bromide (0.5μg/ml) for 30 minutes. PCR products with single, clear bands were puri-
fied using ExoSAP-IT1 (Affymetrix, Santa Clara, CA, USA). Purified DNA (8ng/μl) was then
cycle sequenced using forward or reverse primer (1μM) (Metabion), BigDye1 Terminator
v1.1 Ready Reaction Mix (Applied Biosystems), BigDye1 Terminator Sequencing Buffer (1X)
(Applied Biosystems), and deionized water in a 20μl reaction (cycle sequencing conditions
available in S2 Table). Cycle sequencing cleanup was performed using Performa1 DTR Gel
Filtration Cartridges (EdgeBio, Gaithersburg, MD, USA), and purified sequencing reactions
were run on a 3130xl Genetic Analyzer (Applied Biosystems). Translocation junction se-
quences were aligned to the reference genome using BLAT tool from the UCSC Genome
Browser (https://genome.ucsc.edu/cgi-bin/hgBlat) [33].
Translocation Generation and Position Effect Investigation
In order to get an insight into the mechanisms underlying translocation formation, the area
spanning the translocation junctions was studied for the presence of any repetitive elements
using the RepeatMasker track from the UCSC Genome Browser. In addition, a file containing
highly conserved non-coding sequences (CNEs), found to be associated with developmental
regulators [34], was uploaded as a custom track. This was done to investigate whether the
breakpoints disrupted any of these conserved sequences, and in turn, possibly disrupted the
regulation of important developmental genes located within the same topological domain [35]
as the CNEs (long-range position effect).
Unmasking of a Recessive Mutation Investigation
Intronic PCR primers (Metabion) flanking the exons and intron-exon boundaries of all dis-
rupted genes were designed using Primer3 (PCR primer sequences and conditions are
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available in S3 Table). Before ordering, primer specificity was checked using the in-silico PCR
tool from the UCSC Genome Browser. Bi-directional mutation screening on the alternative
allele was performed using the BigDye1 Terminator v1.1 Cycle Sequencing kit (Applied Bio-
systems) followed by analysis on a 3130xl Genetic Analyzer (Applied Biosystems). Cycle
sequencing reactions and conditions were the same as in the validation of translocation break-
points (S2 Table). Variant detection was done using the BLAT tool from the UCSC Genome
Browser (https://genome.ucsc.edu/cgi-bin/hgBlat) [33].
Uniparental Disomy (UPD) Investigation
Genotyping for UPD7 [36] in family 1 was done by mixing DNA sample from each member
with a mixture of eight fluorescent chromosome (chr)7-specific repeat microsatellite markers
(listed in S4 Table) and a multiplex PCR master mix (Qiagen). Following PCR amplification,
amplified DNA from each sample was mixed with Hi-Di™ Formamide and GeneScan™–500
LIZ1 Size Standard DNA ladder (Applied Biosystems). Finally the samples were run using a
Fragment Analysis protocol on a 3130xl Genetic Analyzer (Applied Biosystems) according to
the manufacturer’s instructions. UPD7 data analysis was done using the Applied Biosystem
GeneMapper v4.1 Software.
Structural Variant Analysis
Processed MPS data were filtered further (detailed description in S1 Supporting Document) in
order to exclude variants overlapping by80% with common SVs reported in the Database of
Genomic Variants (DGV) [37], and identify patient-specific SVs within each family that could
contribute to the observed discordant phenotypes.
Quantitative Real-Time PCR (qRT-PCR) Analysis
In order to validate selected patient-specific structural variants, qRT-PCR was performed
using SsoFast™ Evagreen1 Supermix (Bio-Rad Laboratories Inc., Hercules, CA, USA) and Pri-
mer3-designed PCR primer pairs (0.5μM) (Metabion) spanning the SVs (qRT-PCR primer
sequences are available in S5 Table). An internal control primer-pair at 18q12.2 was selected to
confirm the efficiency of the reaction and normalize the results. All reactions for each primer
pair were run in triplicates on a CFX96 Touch™ Real-Time PCR Detection System machine
(Bio-Rad Laboratories, Inc.), and results were analyzed using the Bio-Rad CFX Manager analy-
sis software (comparative Ct method).
Reference Sequences
The GRCh37/hg19 reference genome assembly was used for annotation of the WG-MPS data,
as well as primer design and data analysis for Sanger sequencing, mutation screening on the
alternative allele of the disrupted genes and qRT-PCR. Annotation of variants identified after
mutation screening was done according to GenBank reference sequences: NM_017954.10 for
CADPS2 and NM_001199013.1 for STPG1.
Results
All nine familial ABT cases were previously found to have apparently balanced translocations
using G-banding, FISH, and array-CGH at the resolution of 1Mb or 200kb. As these families
still remained undiagnosed, a WG-MPS approach was employed as a next step in order to
define the breakpoints to the base-pair level, detect additional SVs and make genotype-pheno-
type correlations. Results of the individual families are presented below:
Breakpoint Mapping in ABT Families with Discordant Phenotypes Using WG-MPS
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Family 1
At the time of the study, the patient was a 14-year old male with ID, psychomotor delay and
epilepsy, carrying a t(1;7)(p36.1;q22) translocation inherited from his non-affected mother
(Fig 1A and 1B). Translocation junction coordinates as predicted by MPS in the affected male
and his non-affected mother are included in Table 1. Sequencing patterns and translocation
breakpoint positions were identical in both family members. Repetitive elements, small imbal-
ances, and microhomology sequences were also observed at each breakpoint site (Fig 2A;
Fig 1. Family 1 results with t(1;7) translocation. A) Family 1 pedigree showing the proband with intellectual disability, psychomotor delay and epilepsy,
as well as the non-affected mother and father. The t(1;7)(p36.1;q22) translocation is maternally inherited. B) Ideograms showing the normal and
derivative (der) chromosomes (chr) 1 and 7 (not to scale). Genetic material from chr1 and chr7 is shown with a solid, orange and dotted, blue frame line,
respectively. The approximate breakpoint positions on 1p36.1 and 7q22 are indicated by arrows. C) UPD7 analysis results from one of the informative
microsatellite markers (D71824) in the affected proband and non-affected parents; by comparing the peak sizes between all family members, normal
biparental inheritance was concluded. D) Quantitative Real-Time PCR results demonstrating the paternal inheritance of the chr3 duplication predicted
from the structural variant analysis in the affected proband.
doi:10.1371/journal.pone.0169935.g001
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Table 1). The breakpoint on der(1) did not disrupt any known gene or CNE located around
developmental regulatory genes. The breakpoint on der(7) disrupted PTCD1 (Pentatricopep-
tide repeat domain 1) (OMIM 614774) (intron 7), as well as the ATP5J2-PTCD1 read-through
transcript (intron 8) (Table 1). Sequencing of all protein-coding exons in the affected member
did not detect any sequence variation as compared to the reference sequence (GRCh37/hg19).
In addition, UPD of chromosome 7 was excluded (Fig 1C; S4 Table).
Table 1. Breakpoint mapping and sequencing results for each apparently balanced translocation case included in this study.
Case /
phenotype
Translocation
junction as
estimated by MPS
Junction
length
Read-
pairs
Translocation
breakpoint position
as defined by SS
Disrupted gene
(s)
Indels
(+strand)
Microho-
mology
Repetitive
elements
Family 1 –t(1;7)(p36.1;q22)
Male with ID,
psychomotor
delay,epilepsy
chr1:18163342–
18163563
222bp 12 chr1:18163344–
18163348
— 3bp-AGT
del.
T SINE-MIR-MIRb
chr7:99019714–
99019855
142bp chr7:99019710–
99019714
PTCD1 &
ATP5J2-PTCD1
3bp-AGA
del.
CC LINE-L1-L1M5
Non-affected
mother
chr1:18163366–
18163436
71bp 17 chr1:18163344–
18163348
— 3bp-AGT
del.
T SINE-MIR-MIRb
chr7:99019342–
99019746
405bp chr7:99019710–
99019714
PTCD1 &
ATP5J2-PTCD1
3bp-AGA
del.
CC LINE-L1-L1M5
Family 2 –t(7;8)(q32;q24.13)
Female with ID chr7:122515289–
122515690
402bp 17 chr7:122515671–
122515672
CADPS2 — C —
chr8:119865523–
119866376
854bp chr8:119866044–
119866050
— 5bp-
GTAAA
del.
TAA —
Non-affected
sibling
chr7:122514386–
122515726
1341bp 20 chr7:122515671–
122515672
CADPS2 — C —
chr8:119866031–
119866086
56bp chr8:119866044–
119866050
— 5bp-
GTAAA
del.
TAA —
Family 3 –t(4;10)(q35;q11.2)
Female with
mild to moderate
ID
chr4:189742584–
189742790
207bp 15 chr4:189742651–
189742656
— 4bp-
ATCG del.
T LINE-L2-L2a
chr10:43139092–
43140045
954bp chr10:43139266–
43139272
— 5bp-
CTGGC
del.
— SINE-Alu-AluSc
Non-affected
sibling
chr4:189742123–
189743225
1103bp 26 chr4:189742651–
189742656
— 4bp-
ATCG del.
T LINE-L2-L2a
chr10:43139186–
43139369
184bp chr10:43139266–
43139272
— 5bp-
CTGGC
del.
— SINE-Alu-AluSc
Non-affected
mother
chr4:189742483–
189743387
905bp 25 chr4:189742651–
189742656
— 4bp-
ATCG del.
T LINE-L2-L2a
chr10:43139065–
43140359
1295bp chr10:43139266–
43139272
— 5bp-
CTGGC
del.
— SINE-Alu-AluSc
Family 4 –t(1;20)(p35.3;q13.3)
Male with
Polysynda-ctyly,
Oral Anomalies
chr1:24738004–
24738807
804bp 13 chr1:24738180–
24738181
STPG1 — C SINE-Alu-AluJr4
chr20:56177192–
56177656
465bp chr20:56177612–
56177613
— 2bp-GA
dupl.
— —
Non-affected
mother
chr1:24738108–
24738220
113bp 15 chr1:24738180–
24738181
STPG1 — C SINE-Alu-AluJr4
chr20:56177454–
56178424
971bp chr20:56177612–
56177613
— 2bp-GA
dupl.
— —
doi:10.1371/journal.pone.0169935.t001
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Fig 2. Translocation junction sequences identified in each family. Translocation junction sequences to the base-pair level as identified
by mate-pair sequencing and verified by Sanger sequencing in A) family 1 with t(1;7)(p36.1;q22), B) family 2 with t(7;8)(q32;q24.13), C) family
3 with t(4;10)(q35;q11.2), and D) family 4 with t(1;20)(p35.3;q13.3). Translocation junction sequences (middle line) and matching reference
sequences (top and bottom lines) are shown with a different colour depending on the chromosome involved (chr1-orange; chr4-purple;
chr7-blue; chr8-red; chr10-yellow; chr20-green). Microhomology observed at the translocation breakpoint sites is highlighted in yellow,
deleted sequences around the breakpoints are underlined, duplicated sequences are in bold, capital letters, and inserted sequences not
aligning to either chromosome are in bold, lower-case letters.
doi:10.1371/journal.pone.0169935.g002
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Translocation junction and exact breakpoint position as identified by Mate Pair Sequencing
(MPS) and Sanger sequencing (SS), respectively, in the affected and non-affected translocation
carriers in each family. The number of read-pairs representing each translocation junction, the
gene(s) disrupted by each translocation breakpoint as well as insertions/deletions (indels),
microhomology and repetitive elements found at the breakpoint sites are indicated. All geno-
mic coordinates are based on the GRCh37/hg19 reference genome assembly. (ID = Intellectual
Disability; mat = maternal; bp = base-pair; del. = deletion; dupl. = duplication)
After filtering our MPS data for common SVs reported previously in DGV (S1 Supporting
Document), nineteen patient-specific SVs (represented by5 reads) were identified (S6 Table).
A large duplication (chr3:50382561–50403806) supported by 22 read-pairs, was selected to be
investigated further with qRT-PCR using DNA samples from the proband, parents and unre-
lated control, and four PCR primer-pairs spanning the predicted duplicated area. Results
revealed a relative copy number increase in both affected proband and non-affected father in
the case of C-RT1, C-RT2, and C-RT3 primer-pairs, while normal results were observed across
all samples relative to the control in the case of C-RT4 primer-pair (Fig 1D).
Family 2
In the second family, two female siblings are carriers of a t(7;8)(q32;q24.13) translocation.
The first sibling was diagnosed with ID, while the other was phenotypically normal. Table 1
includes the MPS-predicted translocation breakpoint junctions on der(7) and der(8) as well as
the identical breakpoint positions identified in both siblings (Table 1). Based on the sequencing
results, none of the breakpoints were located within repetitive sequences. However, 1bp (C) and
3bp (TAA) microhomology was present at each breakpoint site (Fig 2B). The der(8) breakpoint
did not disrupt any protein-coding genes or CNEs. The der(7) breakpoint caused the disruption
of CADPS2 (calcium-dependent secretion activator 2) (OMIM 609978) (intron 1) (Table 1).
Sequencing of all CADPS2 exons on the alternative allele in the affected member detected a sin-
gle known synonymous polymorphic variant (rs2251761) on exon 3 (NM_017954.10) (S3 Fig).
Six patient-specific SVs were identified (S7 Table) and only two of them disrupted known
genes, namely SH3RF3 (SH3 domain containing ring finger 3) and ZNF423 (zinc finger pro-
tein 423) (OMIM 604557). The ~19.6kb deletion (chr16:49741265–49760865) supported by 17
read-pairs and disrupting ZNF423was investigated further with qRT-PCR using DNA samples
from the affected proband, non-affected sibling and control, as well as three primer-pairs
(Z-RT1, Z-RT2, and Z-RT3) spanning the predicted deletion (Fig 3A). Parental genomic mate-
rial was unavailable and thus not included in the analysis. A relative ZNF423 copy number
decrease was observed in the affected proband, but not in the non-affected sibling, compared
with a control sample (Fig 3B). Sequencing of all ZNF423 exons and exon-intron boundaries
revealed no sequence variations as compared to the reference sequence (GRCh37/hg19).
Family 3
The affected member in family 3 was, at the time of the study, a 42-year old female presenting
with mild to moderate ID. Chromosome analysis revealed a t(4;10)(q35;q11.2) translocation
which was shared between her non-affected brother and non-affected mother. Individual
translocation breakpoint junctions as well as identical breakpoint positions and sequencing
patterns in all family members are indicated in Table 1 and Fig 2C. No genes were disrupted
by the translocation breakpoints. In addition, no CNEs were located up to 1Mb upstream or
downstream either breakpoint.
Eleven different SVs, not recorded in DGV, were identified uniquely in the affected translo-
cation carrier (S8 Table). Only 4 rearrangements disrupted known genes: ATG4C (autophagy
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related 4C, cysteine peptidase) (OMIM 611339), RAP1GDS1 (RAP1, GTPase-GDP dissocia-
tion stimulator 1) (OMIM 179502), TP53TG3 (TP53 target 3) and ZNF383 (zinc finger protein
383). Based on their functions none appeared to be associated with intellectual disability pre-
sented in the patient, therefore, no further investigation was carried out.
Family 4
At the time of the study, the patient in family 4 was a 3-year old male presenting with
polysyndactyly and oral anomalies. Chromosome analysis revealed a t(1;20)(p35.3;q13.3)
translocation which was inherited from his non-affected mother. Despite the different
translocation junctions predicted by MPS, the breakpoint positions and sequencing pat-
terns were exactly the same in both family members (Table 1). Microhomology (1bp-C) was
observed only at the der(1) breakpoint, which was also located within SINE/Alu/AluJr4
repeats (Table 1; Fig 2D). Disruption of STPG1 (Sperm-tail PG-rich repeat containing 1)
(OMIM 615826) (intron 1) occurred at the der(1) breakpoint site, whereas no CNEs were
located at either breakpoint region. Sequencing of all STPG1 gene exons on the alternative
allele in the patient revealed two known polymorphic variants on exon 5 (NM_001199013.
1): rs1064842 and rs1142057 (S4 Fig).
MPS data filtering for known variants reported in DGV and common variants between
the two family members revealed six patient-specific SVs (S9 Table). A single known gene
(ECHDC1- ethylmalonyl-CoA decarboxylase 1) (OMIM 612136) was disrupted by two sepa-
rate SVs; however, it appears unlikely that it is causally linked to the patient’s phenotype.
Fig 3. The ZNF423 gene and quantitative Real-Time PCR (qRT-PCR) results. A) Schematic illustration of the ZNF423 gene (minus strand). The
protein-coding exons and introns of the gene are represented with solid, vertical lines and dotted, horizontal lines, respectively (not to scale). Intron 3 is
enlarged to demonstrate the approximate ZNF423 deletion position (blue line) as predicted by MPS in the affected sibling in family 2, as well as the
amplicon (Z-RT1, Z-RT2, and Z-RT3) positions (red lines) from the qRT-PCR analysis. The actual coordinates are given on the left (GRCh37/hg19). B)
qRT-PCR results demonstrating a reduced relative ZNF423 copy number in the proband and normal results in the non-affected sibling as compared with a
control. Parental genomic material was unavailable and thus not included in the analysis.
doi:10.1371/journal.pone.0169935.g003
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Discussion
Currently, there is very limited literature regarding the genetic causality of familial ABTs in
cases where one member is clinically affected and the other(s) is/are phenotypically normal.
To our knowledge, only a single study has addressed similar challenges and has investigated
only one family. Specifically, large-insert paired-end tag NGS was used to investigate a t(6;8)
balanced translocation shared between an asymptomatic mother and her two affected chil-
dren. A disease candidate gene was disrupted at one of the two translocation breakpoint sites
but no additional mutations on the other allele were detected. It was concluded that further
functional studies were needed to establish pathogenicity [38]. The present study is the largest
one conducted so far, which thoroughly investigated all possible mechanisms leading to dis-
cordant phenotypes, in nine cases with identical ABTs in each of the four families.
Initially, the genes disrupted by the ABT breakpoints that could potentially constitute dis-
ease candidate genes were identified through WG-MPS and subsequently Sanger sequencing.
These were PTCD1 and ATP5J2-PTCD1 in family 1, CADSP2 in family 2, and STPG1 in family
4. PTCD1 is a gene implicated in the regulation of mitochondrial gene expression and the neg-
ative regulation of leucine tRNA levels in the mitochondria [39,40]. Mitochondrial dysfunction
has been linked to epilepsy [41], which agrees with the phenotype of the family 1 affected case.
However, so far PTCD1 has not been associated with inherited diseases. Furthermore, the
function of the ATP5J2-PTCD1 read-through transcript is completely unknown. Currently
there exists minimal information regarding the function of STPG1, the gene disrupted in fam-
ily 4 examined here, besides a potential role in induced apoptosis pathways [42]. In this study,
subsequent examination of PTCD1,ATP5J2-PTCD1 and STPG1 coding exons on the alterna-
tive allele did not identify any point mutations in the affected members that could result in
complete loss-of-function of these genes.
CADPS2, the gene disrupted by the translocation in family 2, maps within the autism sus-
ceptibility locus 1 on 7q31-q33 and has been linked in a number of studies with ID and autism
[43,44]. It has been shown that knockout of CADPS2 in mouse models impairs cerebellar
development and function [45]. Knockout mice also display autistic-like behaviours, and alter-
native splicing of CADPS2 mRNA lacking exon 3 has been observed in some autistic patients
[43]. In a recent study, it was reported that CADPS2 expression is subject to a parent-of-origin
effect, with only the maternal allele being expressed in blood and amygdala [44]. However,
because parental genomic material was not available in family 2 we could not determine
whether the translocation was inherited, and also UPD7 was not excluded. Even though
CADPS2 could be a possible disease candidate gene based on its function and previous studies,
no pathogenic point mutations were identified on the alternative allele in the affected individ-
ual that could explain the phenotypic differences between the two siblings. As the same trans-
location was also present in the phenotypically normal sibling, this observation suggests that if
CADPS2 disruption contributes to the patient’s phenotype, it must be through incomplete pen-
etrance, imprinting or other mechanisms.
As a next step, a structural variant analysis was performed by filtering WG-MPS data for
common variants reported in DGV. This enabled us to reduce the WG-MPS data volume and
identify patient-specific variants that could possibly account for the discordant phenotypes
observed between carriers of the same translocation. Selected disease candidate variants were
confirmed by qRT-PCR. For example, a family 1 patient-specific large duplication (~21kb)
was investigated further as disruption of CACNA2D2 (calcium voltage-gated channel auxiliary
subunit alpha2delta 2) (OMIM 607082), one of the genes within the duplicated region, has
been previously reported in patients with epilepsy and developmental delay [46,47]. A relative
copy number increase was detected in the affected proband, as compared with a control, by
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using primer-pairs C-RT1, C-RT2, and C-RT3 (Fig 1D). A normal copy number state was
observed by using C-RT4, which is probably due to the fact that the amplified area falls outside
the actual duplication breakpoints. The same profile was also observed in the non-affected
father, suggesting that the duplication was paternally inherited. Since the same duplication was
detected in both affected and non-affected individuals, it appears that the phenotypic conse-
quence of the duplicated CACNA2D2 gene (exons 36–39) is most probably non-pathogenic.
However, as in the case of CADPS2, incomplete penetrance should also be considered.
qRT-PCR was also performed to validate a ~19.6kb deletion (chr16:49741265–49760865)
disrupting ZNF423 in the affected t(7;8) carrier in family 2. Reduced relative ZNF423 copy
number was observed in the affected sibling, as compared with a control, thus confirming the
deletion (Fig 3B). Normal results were identified in the non-affected sibling; however, we
could not determine whether the deletion was inherited as parental genomic material was
unavailable. The ZNF423 gene encodes for a zinc finger transcription factor (ZFP423) that is
involved in cerebellar development [48,49]. 16q12 microdeletions encompassing ZNF423 as
well as other genes have been reported in patients with various developmental phenotypes
[50–53]. The ZNF423 deletion reported here is the smallest and covers ZNF423 intron 2. Based
on the amplicon positions showing a reduced relative ZNF423 copy number, the deletion
breakpoints can be refined between 49746990 and 49758761 (Fig 3A); however, the actual
breakpoints may extend beyond these positions. Since ZNF423 is highly expressed in the brain
and ZNF423 disruption results in phenotypes resembling those seen in our patient, we tested
next whether there were any pathogenic mutations unmasked on the other allele. Sequencing
though of all ZNF423 exons did not detect any sequence variations in the affected translocation
carrier as compared to the reference sequence (GRCh37/hg19).
To summarize, based on the results from a thorough investigation of the mechanisms that
could possibly underlie the phenotypic differences between carriers of the same translocations,
unmasking of recessive gene mutations by the translocations has been excluded, and wherever
applicable, the possibility of uniparental disomy (family 1). Furthermore, none of the identi-
fied rearrangement breakpoints occurred within obvious candidate regions for long-range
position effects. In families 1, 3, and 4, presence of cryptic imbalances or complex chromo-
somal rearrangements that could be causative for the discordant phenotypes observed within
each family has also been excluded. The ZNF423 deletion detected in the affected individual in
family 2 may have a causative link to the patient’s phenotype; however, possible inheritance of
the deletion has to be excluded, and functional studies are required in order to verify possible
haploinsufficiency mechanisms underlying such positive association.
WG-MPS with long-insert libraries used in the current study proved highly successful in
identifying familial ABT breakpoints. In total, eighteen translocation breakpoint junctions
(two from each of the nine cases) were mapped down to a region ranging between 56bp and
1.3kb. This allowed further delineation to the nucleotide level with the use of a single-primer
pair flanking each derivative chromosome breakpoint, per family, and by following standard
PCR and Sanger sequencing procedures. In each family, identical breakpoint positions and
sequencing patterns were identified in both affected and non-affected members carrying the
same translocation. Similar to our study, the effective application of whole-genome NGS-
based methods in identifying familial balanced translocation breakpoints was demonstrated in
a recent study by Liang et al., 2016 [54]. In their parental study, eight families were investigated
that could potentially carry balanced translocations based on prenatal cases with unbalanced
karyotypes. G-banding and FISH analyses detected three balanced translocations and two sub-
microscopic balanced translocations, respectively, while low coverage whole-genome paired-
end sequencing (WG-PES) detected all five translocations. It was concluded that WG-PES
may replace conventional cytogenetic methods for the clinical identification of balanced
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translocation carriers [54], and results from our study using a similar NGS-based method fur-
ther support this.
Apart from breakpoint mapping, sequencing to the base-pair level can also offer insights
into possible mechanisms involved in ABT generation. In our study, molecular characteriza-
tion of the breakpoints showed that they occurred in repetitive sequences in three out of four
families. However, absence of homologous regions on both chromosomes involved in each
translocation argues against non-allelic homologous recombination (NAHR). Instead, the
presence of microhomology and/or small imbalances around the breakpoint sites (Table 1; Fig
2) suggests that the translocations were likely generated by microhomology-mediated repair
(MHMR) [55] or non-homologous end-joining (NHEJ) [56] of double-strand breaks. These
results come in agreement with previous studies reporting that following double-strand
breaks, NHEJ is the predominant repair mechanism leading to translocations rather than
NAHR [57].
In conclusion, our data has demonstrated that WG-MPS is a highly powerful tool that
allows rapid and accurate mapping of familial ABT breakpoints as well as identification of sin-
gle genes disrupted at the breakpoints and detection of additional patient-specific variants.
A number of studies have identified genes disrupted by de novo translocations that are pla-
usibly linked to the patient’s phenotype. However, based on the results presented here, it
appears that in the majority of familial two-way ABT cases, in which the presence of cryptic
imbalances or complex chromosomal rearrangements has been excluded, translocations are
unrelated to the phenotype, unlike de novo translocations. Future analysis of our ABT families
with whole-exome or whole-genome sequencing can potentially reveal the presence of uniden-
tified pathogenic mutations in the affected individuals and provide additional evidence that
the phenotype in the patients occurred independent of the detected ABTs. In addition, the
exact frequency of the phenotypic risk in ABT families can be clarified in the future through
the examination of larger cohorts of familial ABT cases, which will be of great importance for
genetic counseling.
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